Command Palette

Search for a command to run...

Clinical Trials · NCT05579249

A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

CompletedPhase 4Semaglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Novo Nordisk A/S
Enrollment
500
Start date
Jan 2023
Locations
1 site, United States
Primary endpoint
Number of Participants Who Achieved Greater Than or Equal to (≥) 10.0 Percent (%) Body Weight Reduction (Yes/no)
View Semaglutide compound reference